Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1973 Apr;7(4):539–546. doi: 10.1128/iai.7.4.539-546.1973

Differences in Clinical and Convalescent-Phase Antibodies of Rhesus Monkeys Infected with Monkey Pox, Tanapox, and Yaba Poxviruses

R D Hall a,1, R G Olsen a, S P Pakes a,2, D S Yohn a
PMCID: PMC422718  PMID: 4357602

Abstract

Complement-fixing and complement-fixing inhibiting (CFI) antibodies were demonstrated in the clinical and convalescent stages, respectively, of rhesus monkeys infected with either monkey poxvirus, Tanapoxvirus, or Yaba poxvirus. Specificity of the CFI antibody was confirmed by its failure to cross-react with heterologous poxvirus antigens and by experiments demonstrating the CFI test as being antigen dependent. Serum containing CFI antibody neutralized homologous poxvirus but failed to agglutinate antigen-coated, tanned red blood cells. The application of CFI test as a seroepidemiologic tool for studies of poxvirus infection of man and simian monkeys and the biologic role of CFI antibody in pathogenesis were discussed.

Full text

PDF
539

Images in this article

542Image
on p.542

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEARCROFT W. G., JAMIESON M. F. An outbreak of subcutaneous tumours in rhesus monkeys. Nature. 1958 Jul 19;182(4629):195–196. doi: 10.1038/182195a0. [DOI] [PubMed] [Google Scholar]
  2. BENACERRAF B., OVARY Z., BLOCH K. J., FRANKLIN E. C. Properties of guinea pig 7S antibodies. I. Electrophoretic separation of two types of guinea pig 7S antibodies. J Exp Med. 1963 Jun 1;117:937–949. doi: 10.1084/jem.117.6.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRUMFIELD H. P., POMEROY B. S. Direct complement fixation by turkey and chicken serum in viral systems. Proc Soc Exp Biol Med. 1957 Jan;94(1):146–149. doi: 10.3181/00379727-94-22881. [DOI] [PubMed] [Google Scholar]
  4. Casey H. W., Woodruff J. M., Butcher W. I. Electron microscopy of a benign epidermal pox disease of rhesus monkeys. Am J Pathol. 1967 Sep;51(3):431–446. [PMC free article] [PubMed] [Google Scholar]
  5. Crandell R. A., Casey H. W., Brumlow W. B. Studies of a newly recognized poxvirus of monkeys. J Infect Dis. 1969 Jan;119(1):80–88. doi: 10.1093/infdis/119.1.80. [DOI] [PubMed] [Google Scholar]
  6. HOTCHIN J., WEIGAND H. Studies of lymphocytic choriomeningitis in mice. I. The relationship between age at inoculation and outcome of infection. J Immunol. 1961 Apr;86:392–400. [PubMed] [Google Scholar]
  7. Hellström I., Evans C. A., Hellström K. E. Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomas. Int J Cancer. 1969 Sep 15;4(5):601–607. doi: 10.1002/ijc.2910040504. [DOI] [PubMed] [Google Scholar]
  8. ITOH H., MELNICK J. L. The infection of chimpanzees with ECHO viruses. J Exp Med. 1957 Nov 1;106(5):677–688. doi: 10.1084/jem.106.5.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McGuire T. C., Van Hoosier G. L., Jr, Henson J. B. The complement-fixation reaction in eguine infectious anemia: demonstration of inhibition by IgG (T). J Immunol. 1971 Dec;107(6):1738–1744. [PubMed] [Google Scholar]
  10. OVARY Z., BLOCH K. J., BENACERRAF B. IDENTIFICATION OF RABBIT, MONKEY, AND DOG ANTIBODIES WITH PCA ACTIVITY FOR GUINEA PIGS. Proc Soc Exp Biol Med. 1964 Jul;116:840–845. doi: 10.3181/00379727-116-29388. [DOI] [PubMed] [Google Scholar]
  11. Olsen R. G., McCammon J. R., Yohn D. S. Simplified procedure for preparation of specific antibodies to gamma globulins. Appl Microbiol. 1970 Jul;20(1):75–77. doi: 10.1128/am.20.1.75-77.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Olsen R. G., Yohn D. S. Demonstration of antibody in cat sera to feline oncornavirus by complement-fixation inhibition. J Natl Cancer Inst. 1972 Aug;49(2):395–403. [PubMed] [Google Scholar]
  13. Olsen R. G., Yohn D. S. Immunodiffusion analysis of Yaba poxvirus structural and associated antigens. J Virol. 1970 Feb;5(2):212–220. doi: 10.1128/jvi.5.2.212-220.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. PRIER J. E., SAUER R. M., MALSBERGER R. G., SILLAMAN J. M. Studies on a pox disease of monkeys. II. Isolation of the etiologic agent. Am J Vet Res. 1960 May;21:381–384. [PubMed] [Google Scholar]
  15. Rabotti G. F., Blackham E. Immunological determinants of avian sarcoma viruses: presence of group-specific antibodies in fowl sera demonstrated by complement-fixation inhibition test. J Natl Cancer Inst. 1970 May;44(5):985–991. [PubMed] [Google Scholar]
  16. SCHMIDT N. J., HARDING H. B. The demonstration of substances in human sera which inhibit complement fixation in antigen-antibody systems of lymphogranuloma venereum, psittacosis, mumps, Q fever, and lymphocytic choriomeningitis. J Bacteriol. 1956 Feb;71(2):217–222. doi: 10.1128/jb.71.2.217-222.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wenner H. A., Macasaet F. D., Kamitsuka P. S., Kidd P. Monkey pox. I. Clinical, virologic and immunologic studies. Am J Epidemiol. 1968 May;87(3):551–566. doi: 10.1093/oxfordjournals.aje.a120846. [DOI] [PubMed] [Google Scholar]
  18. YOHN D. S., GRACE J. T., Jr, HAENDIGES V. A. A QUANTITATIVE CELL CULTURE ASSAY FOR YABA TUMOUR VIRUS. Nature. 1964 May 30;202:881–883. doi: 10.1038/202881a0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES